Your search for tofacitinib returned 2 results

Clinical efficacy of the oral Janus kinase inhibitor tofacitinib at Month 6 was greater than placebo and “appeared similar regardless of methotrexate dose” in patients with rheumatoid arthritis a post-hoc analysis presented at the 2015 ACR/ARHP Annual Meeting has found.

Part of the challenge of effective management of noninfectious uveitis is that it is not really a single disease, but a constellation of many different ones.